Clinical Trials Browser

Cholangiocarcinoma × ivosidenib × 90 days × Clear all

NCT07260175 2026-03-23

adIVO

Phase 2 Recruiting

Gastrointestinal

Cholangiocarcinoma

NCT05876754 2026-02-19

ProvIDHe

Phase 3 Recruiting

Gastrointestinal

Cholangiocarcinoma

NCT02073994 2026-02-17

Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation

Phase 1 Completed

CNSGastrointestinalSarcoma

Chondrosarcoma, Glioma, Cholangiocarcinoma